Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study - Salvi, M; Vannucchi, G; Campi, I; Currò, N; Dazzi, D; Simonetta, S; Bonara, P; Rossi, S; Sina, C; Guastella, C; Ratiglia, R; Beck-Peccoz, P (Eur J Endocrinol, 2007)